| scholarly article | Q13442814 |
| P50 | author | Matthias Kretzler | Q30004156 |
| Stephen M. Hewitt | Q30361876 | ||
| Avi Rosenberg | Q37366935 | ||
| Howard Trachtman | Q40416827 | ||
| Pietro A Canetta | Q56855760 | ||
| P2093 | author name string | Gerald B Appel | |
| Laura H Mariani | |||
| Sebastian Martini | |||
| Jeffrey B Hodgin | |||
| Laura Barisoni | |||
| Hui-Ping Chien | |||
| Serena M Bagnasco | |||
| Jarcy Zee | |||
| Kevin V Lemley | |||
| Matthew Palmer | |||
| Abigail Smith | |||
| Jonathan P Troost | |||
| P2860 | cites work | What is the best way to measure renal fibrosis?: A pathologist’s perspective | Q26796641 |
| Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes | Q26799177 | ||
| Cellular and molecular mechanisms in kidney fibrosis | Q33685938 | ||
| Reproducibility of the NEPTUNE descriptor-based scoring system on whole-slide images and histologic and ultrastructural digital images | Q33915270 | ||
| Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors | Q33988765 | ||
| Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. | Q34181871 | ||
| The classification of glomerulonephritis in systemic lupus erythematosus revisited | Q34293066 | ||
| International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | Q34354852 | ||
| Morphometric and visual evaluation of fibrosis in renal biopsies | Q34457313 | ||
| Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE) | Q34580772 | ||
| The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification | Q34658768 | ||
| Histopathologic classification of ANCA-associated glomerulonephritis | Q34660132 | ||
| MicroRNA-21 in glomerular injury | Q35228513 | ||
| Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy | Q35364638 | ||
| The MEST score provides earlier risk prediction in lgA nephropathy | Q35892267 | ||
| Morphometry Predicts Early GFR Change in Primary Proteinuric Glomerulopathies: A Longitudinal Cohort Study Using Generalized Estimating Equations. | Q36048331 | ||
| The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies | Q36054132 | ||
| Renal fibrosis: new insights into the pathogenesis and therapeutics | Q36366487 | ||
| Complete Remission in the Nephrotic Syndrome Study Network | Q36432859 | ||
| Prognostic factors in lupus nephritis. Contribution of renal histologic data | Q36600287 | ||
| Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study | Q36665755 | ||
| Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach | Q36728772 | ||
| Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis | Q36763871 | ||
| Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy | Q36770851 | ||
| Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker | Q36883839 | ||
| Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population | Q38086275 | ||
| Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification | Q38148703 | ||
| GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration | Q38274063 | ||
| Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN | Q38633087 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis | Q41225874 | ||
| Computerized image analysis vs semiquantitative scoring in evaluation of kidney allograft fibrosis and prognosis | Q45072882 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. | Q47210601 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| Structural-functional correlations in renal disease. II. The correlations. | Q53005548 | ||
| Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. | Q53005556 | ||
| Pathologic classification of diabetic nephropathy. | Q55052603 | ||
| Pathologic classification of focal segmental glomerulosclerosis: a working proposal | Q56008651 | ||
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy | Q79301271 | ||
| Differential expression of profibrotic and growth factors in chronic allograft nephropathy | Q82547242 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 310-318 | |
| P577 | publication date | 2017-02-27 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. | |
| P478 | volume | 33 |
| Q47372786 | An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis. |
| Q90605212 | Artificial intelligence driven next-generation renal histomorphometry |
| Q55332093 | Association of Pathological Fibrosis With Renal Survival Using Deep Neural Networks. |
| Q93013863 | CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease |
| Q98733550 | Digital pathology and computational image analysis in nephropathology |
| Q38368429 | Digital pathology in nephrology clinical trials, research, and pathology practice |
| Q42650630 | Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits |
| Q92884447 | Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney disease |
| Q95328312 | Integrated multi-omics approaches to improve classification of chronic kidney disease |
| Q40065312 | Intrinsic renal cells induce lymphocytosis of Th22 cells from IgA nephropathy patients through B7-CTLA-4 and CCL-CCR pathways |
| Q92901831 | Markers of renal fibrosis: How do they correlate with podocyte damage in glomerular diseases? |
| Q60787260 | Metabolic pathways and immunometabolism in rare kidney diseases |
| Q38701041 | Renal biopsy-driven molecular target identification in glomerular disease |
| Q89454159 | Renal matrix Gla protein expression increases progressively with CKD and predicts renal outcome |
| Q88984435 | The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study |
| Q92503838 | The many talents of transforming growth factor-β in the kidney |
| Q64061354 | Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy |
| Q93080015 | Tyro3 is a podocyte protective factor in glomerular disease |
| Q91845232 | Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome |
Search more.